Compare Humana Inc (HUM) vs Nu Holdings Ltd (NU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Nu Holdings Ltd — how do they compare? Humana Inc trades at $436 (market cap $46.49B), while Nu Holdings Ltd trades at $16.08 (market cap $74.30B). The key difference: Nu Holdings Ltd is the larger of the two by market cap, and Humana Inc pays a 0.91% dividend while Nu Holdings Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Nu Holdings Ltd for 53 Days on average.
| HUM | NU | |
|---|---|---|
Market Cap | $46.49B | $74.30B |
Volume | 2,567,704 | 80,294,805 |
Sector | Health | Financials |
52-Week High | $409.85 | $18.76 |
52-Week Low | $163.67 | $11.60 |
Typical Hold Time | 51 Days | 53 Days |
Enterprise Value | $53.84B | $96.91B |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $431.03, up 8.71% over the past day, reflecting strong momentum following a Barclays upgrade and positive earnings beats. The stock exhibits a bullish technical trend, with support at $378 and resistance at $394. Revenue has grown steadily from $92.9B in 2022 to $129.7B in 2025, though net income margins have compressed to 0.88%. Analyst consensus is a Buy with a $457.05 price target, and recent news highlights corporate initiatives and institutional investments.
The outlook for HUM is cautiously optimistic, driven by revenue growth and analyst support, but risks include margin pressure and regulatory scrutiny. Investment opportunity lies in execution of Medicare Advantage strategies, while key risks involve competitive pressures and potential fiduciary concerns highlighted in recent shareholder notices.
NU Holdings stock trades at $16.12, up 3.47% today, with a bullish technical outlook from moving averages. The company reported strong revenue growth, with 2025 revenue reaching $10.63 billion and net income of $2.87 billion, though recent quarterly EPS results have been mixed. Analyst consensus is bullish with a $16.53 price target, and sentiment is positive following the denial of Monzo acquisition talks.
The outlook for NU remains positive due to robust profitability and expanding customer base, but risks include credit quality concerns and high valuation multiples. Upside potential exists if earnings growth continues, yet investors face volatility from acquisition speculation and competitive pressures in digital banking.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Nu Holdings Ltd
Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.
Read more on NU →
